Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORPPAHC · Entity 4671 | Pres Animal Health & Nutr N.A. | January 15, 2019 | January 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PHIBRO ANIMAL HEALTH CORP
Report date January 15, 2019 · Filed January 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-01-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-01-15 · Exercise / conversion · Acquired 21,560 · Balance 21,560 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Row 2 · 2019-01-15 · Sale · Disposed 21,560 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.49 to $32.38, inclusive. |
| Option to purchase Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2019-01-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-01-15 · Exercise / conversion · Disposed 1,670 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. |
| Option to purchase Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.83 · Expires 2019-02-28 | Direct | 0 |
Reported balance
After 2019-01-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-01-15 · Exercise / conversion · Disposed 19,890 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.49 to $32.38, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 19,890 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · derivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,890 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,670 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · derivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,670 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 21,560 | $31.81 | $685,823.60 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.49 to $32.38, inclusive. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 21,560 | $11.83 | $255,054.80 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · derivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,670 Underlying: Class A Common Stock · 10,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 200 | $43.40 | $8,680.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 9,800 | $42.83 | $419,734.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.23, inclusive. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,000 | $11.83 | $118,300.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 8,220 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · derivative · entry 6 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,670 Underlying: Class A Common Stock · 8,220 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,780 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · derivative · entry 5 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,780 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 3,660 | $46.74 | $171,068.40 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · nonDerivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.65 to $46.80, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 6,340 | $46.18 | $292,781.20 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · nonDerivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.65 to $46.60, inclusive. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 8,220 | $11.83 | $97,242.60 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:09 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 1,780 | $11.83 | $21,057.40 |
DisclosureSEC source: 0001144204-18-037417 · tv498025_4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| February 09, 2018 Filed Feb 14, 2018 02:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-008231 · tv485590_4.xml · derivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780 Underlying: Class A Common Stock · 10,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| February 09, 2018 Filed Feb 14, 2018 02:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 10,000 | $35.62 | $356,200.00 |
DisclosureSEC source: 0001144204-18-008231 · tv485590_4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.95, inclusive. Read SEC document |
| February 09, 2018 Filed Feb 14, 2018 02:11 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,000 | $11.83 | $118,300.00 |
DisclosureSEC source: 0001144204-18-008231 · tv485590_4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| September 15, 2017 Filed Sep 21, 2017 01:15 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-17-048963 · v475529_form4.xml · derivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,780 Underlying: Class A Common Stock · 10,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. Read SEC document |
| September 15, 2017 Filed Sep 21, 2017 01:15 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 5,600 | $35.89 | $200,984.00 |
DisclosureSEC source: 0001144204-17-048963 · v475529_form4.xml · nonDerivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.75 to $35.90, inclusive. Read SEC document |
| September 15, 2017 Filed Sep 21, 2017 01:15 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 4,400 | $35.46 | $156,024.00 |
DisclosureSEC source: 0001144204-17-048963 · v475529_form4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 to $35.70, inclusive. Read SEC document |
| September 15, 2017 Filed Sep 21, 2017 01:15 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,000 | $11.83 | $118,300.00 |
DisclosureSEC source: 0001144204-17-048963 · v475529_form4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. Read SEC document |
| May 11, 2017 Filed May 16, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001571049-17-005043 · t1701574-x1.xml · derivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,780 Underlying: Class A Common Stock · 10,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. Read SEC document |
| May 11, 2017 Filed May 16, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | SaleClass A Common Stock | 10,000 | $33.54 | $335,400.00 |
DisclosureSEC source: 0001571049-17-005043 · t1701574-x1.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.25 to $33.78, inclusive. Read SEC document |
| May 11, 2017 Filed May 16, 2017 01:00 UTC | PHIBRO ANIMAL HEALTH CORP PAHC · Entity 4671 | Exercise / conversionClass A Common Stock | 10,000 | $11.83 | $118,300.00 |
DisclosureSEC source: 0001571049-17-005043 · t1701574-x1.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.